These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 33797167)

  • 1. TGF-β superfamily co-receptors in cancer.
    Pawlak JB; Blobe GC
    Dev Dyn; 2022 Jan; 251(1):137-163. PubMed ID: 33797167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles for the type III TGF-beta receptor in human cancer.
    Gatza CE; Oh SY; Blobe GC
    Cell Signal; 2010 Aug; 22(8):1163-74. PubMed ID: 20153821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor-promoting role for soluble TβRIII in glioblastoma.
    Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
    Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.
    Kirkbride KC; Townsend TA; Bruinsma MW; Barnett JV; Blobe GC
    J Biol Chem; 2008 Mar; 283(12):7628-37. PubMed ID: 18184661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.
    Choi AS; Jenkins-Lane LM; Barton W; Kumari A; Lancaster C; Raulerson C; Ji H; Altomare D; Starr MD; Whitaker R; Phaeton R; Arend R; Shtutman M; Nixon AB; Hempel N; Lee NY; Mythreye K
    Cell Commun Signal; 2024 Feb; 22(1):128. PubMed ID: 38360757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK1 regulates the internalization of endoglin and the type III TGF-β receptor.
    Tazat K; Pomeraniec-Abudy L; Hector-Greene M; Szilágyi SS; Sharma S; Cai EM; Corona AL; Ehrlich M; Blobe GC; Henis YI
    Mol Biol Cell; 2021 Apr; 32(7):605-621. PubMed ID: 33566682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta.
    Glinka Y; Stoilova S; Mohammed N; Prud'homme GJ
    Carcinogenesis; 2011 Apr; 32(4):613-21. PubMed ID: 21186301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.
    Lee JD; Hempel N; Lee NY; Blobe GC
    Carcinogenesis; 2010 Feb; 31(2):175-83. PubMed ID: 19955393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
    Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
    Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics.
    Delolme F; Anastasi C; Alcaraz LB; Mendoza V; Vadon-Le Goff S; Talantikite M; Capomaccio R; Mevaere J; Fortin L; Mazzocut D; Damour O; Zanella-Cléon I; Hulmes DJ; Overall CM; Valcourt U; Lopez-Casillas F; Moali C
    Cell Mol Life Sci; 2015 Mar; 72(5):1009-27. PubMed ID: 25260970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
    Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
    J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.
    Esparza-Lopez J; Montiel JL; Vilchis-Landeros MM; Okadome T; Miyazono K; López-Casillas F
    J Biol Chem; 2001 May; 276(18):14588-96. PubMed ID: 11278442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family.
    Kim SK; Henen MA; Hinck AP
    Exp Biol Med (Maywood); 2019 Dec; 244(17):1547-1558. PubMed ID: 31601110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.
    Elderbroom JL; Huang JJ; Gatza CE; Chen J; How T; Starr M; Nixon AB; Blobe GC
    Mol Biol Cell; 2014 Aug; 25(16):2320-32. PubMed ID: 24966170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.
    You HJ; How T; Blobe GC
    Carcinogenesis; 2009 Aug; 30(8):1281-7. PubMed ID: 19325136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of type III TGF-β receptor aggravates lung fibrotic process.
    Ahn JY; Park S; Yun YS; Song JY
    Biomed Pharmacother; 2010 Sep; 64(7):472-6. PubMed ID: 20359848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
    Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
    J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors.
    Bizet AA; Liu K; Tran-Khanh N; Saksena A; Vorstenbosch J; Finnson KW; Buschmann MD; Philip A
    Biochim Biophys Acta; 2011 May; 1813(5):742-53. PubMed ID: 21295082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
    Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.